Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[ALK is rendered oncogenic as a result of its fusion to NPM1 in anaplastic large cell lymphoma, to TPM3 or TPM4 in inflammatory myofibroblastic tumor, to EML4 in non-small cell lung carcinoma, and to VCL in renal medullary carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[ALK is rendered oncogenic as a result of its fusion to NPM1 in anaplastic large cell lymphoma, to TPM3 or TPM4 in inflammatory myofibroblastic tumor, to EML4 in non-small cell lung carcinoma, and to VCL in renal medullary carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP820745.RATLFEzna24o7OMP_cD6IEbOg4qVxiyiDzxRlDYr_BAVA130_assertion description "[ALK is rendered oncogenic as a result of its fusion to NPM1 in anaplastic large cell lymphoma, to TPM3 or TPM4 in inflammatory myofibroblastic tumor, to EML4 in non-small cell lung carcinoma, and to VCL in renal medullary carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP820745.RATLFEzna24o7OMP_cD6IEbOg4qVxiyiDzxRlDYr_BAVA130_provenance.
• assertion description "[ALK is rendered oncogenic as a result of its fusion to NPM1 in anaplastic large cell lymphoma, to TPM3 or TPM4 in inflammatory myofibroblastic tumor, to EML4 in non-small cell lung carcinoma, and to VCL in renal medullary carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP727763.RAa2qMLI_2aYcYda5HvWs-2z2KzU2z7z9kP8bjSjmgYUw130_assertion description "[ALK is rendered oncogenic as a result of its fusion to NPM1 in anaplastic large cell lymphoma, to TPM3 or TPM4 in inflammatory myofibroblastic tumor, to EML4 in non-small cell lung carcinoma, and to VCL in renal medullary carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP727763.RAa2qMLI_2aYcYda5HvWs-2z2KzU2z7z9kP8bjSjmgYUw130_provenance.
• NP406568.RAy8dbONqka-C9GxMTopcdN-yvNF8koeIkklXohzvdXfw130_assertion description "[ALK is rendered oncogenic as a result of its fusion to NPM1 in anaplastic large cell lymphoma, to TPM3 or TPM4 in inflammatory myofibroblastic tumor, to EML4 in non-small cell lung carcinoma, and to VCL in renal medullary carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP406568.RAy8dbONqka-C9GxMTopcdN-yvNF8koeIkklXohzvdXfw130_provenance.
• NP516530.RAEeH1TGaXjBm885qYiKDVD56SAen2hc2DeGv17KTf1jI130_assertion description "[ALK is rendered oncogenic as a result of its fusion to NPM1 in anaplastic large cell lymphoma, to TPM3 or TPM4 in inflammatory myofibroblastic tumor, to EML4 in non-small cell lung carcinoma, and to VCL in renal medullary carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP516530.RAEeH1TGaXjBm885qYiKDVD56SAen2hc2DeGv17KTf1jI130_provenance.
• assertion description "[ALK is rendered oncogenic as a result of its fusion to NPM1 in anaplastic large cell lymphoma, to TPM3 or TPM4 in inflammatory myofibroblastic tumor, to EML4 in non-small cell lung carcinoma, and to VCL in renal medullary carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[ALK is rendered oncogenic as a result of its fusion to NPM1 in anaplastic large cell lymphoma, to TPM3 or TPM4 in inflammatory myofibroblastic tumor, to EML4 in non-small cell lung carcinoma, and to VCL in renal medullary carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[ALK is rendered oncogenic as a result of its fusion to NPM1 in anaplastic large cell lymphoma, to TPM3 or TPM4 in inflammatory myofibroblastic tumor, to EML4 in non-small cell lung carcinoma, and to VCL in renal medullary carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[ALK is rendered oncogenic as a result of its fusion to NPM1 in anaplastic large cell lymphoma, to TPM3 or TPM4 in inflammatory myofibroblastic tumor, to EML4 in non-small cell lung carcinoma, and to VCL in renal medullary carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP984102.RATaTYH2EokV3IxmVsjJ87JcYQqMT38hEN7rvA-7ztoJ8130_assertion description "[ALK is rendered oncogenic as a result of its fusion to NPM1 in anaplastic large cell lymphoma, to TPM3 or TPM4 in inflammatory myofibroblastic tumor, to EML4 in non-small cell lung carcinoma, and to VCL in renal medullary carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP984102.RATaTYH2EokV3IxmVsjJ87JcYQqMT38hEN7rvA-7ztoJ8130_provenance.
• NP984104.RAZ14Vmzc7sadZ6jx1z9Ob9B4-xGHts22jm0R3Q9n2P0o130_assertion description "[ALK is rendered oncogenic as a result of its fusion to NPM1 in anaplastic large cell lymphoma, to TPM3 or TPM4 in inflammatory myofibroblastic tumor, to EML4 in non-small cell lung carcinoma, and to VCL in renal medullary carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP984104.RAZ14Vmzc7sadZ6jx1z9Ob9B4-xGHts22jm0R3Q9n2P0o130_provenance.
• NP984101.RAAuuQObGeeXmbmCxsyqvWLCP84oICMtSM-ebPeB8GElI130_assertion description "[ALK is rendered oncogenic as a result of its fusion to NPM1 in anaplastic large cell lymphoma, to TPM3 or TPM4 in inflammatory myofibroblastic tumor, to EML4 in non-small cell lung carcinoma, and to VCL in renal medullary carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP984101.RAAuuQObGeeXmbmCxsyqvWLCP84oICMtSM-ebPeB8GElI130_provenance.
• NP984107.RADUozMLV6RjjWxEx6nI8ayosLmJn7yQ8Wy2icMovqMOQ130_assertion description "[ALK is rendered oncogenic as a result of its fusion to NPM1 in anaplastic large cell lymphoma, to TPM3 or TPM4 in inflammatory myofibroblastic tumor, to EML4 in non-small cell lung carcinoma, and to VCL in renal medullary carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP984107.RADUozMLV6RjjWxEx6nI8ayosLmJn7yQ8Wy2icMovqMOQ130_provenance.
• NP235760.RAPAb0UTWbMkVaA7ah95HLSK2n3458okO1X7e6dOe5oQ8130_assertion description "[ALK is rendered oncogenic as a result of its fusion to NPM1 in anaplastic large cell lymphoma, to TPM3 or TPM4 in inflammatory myofibroblastic tumor, to EML4 in non-small cell lung carcinoma, and to VCL in renal medullary carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP235760.RAPAb0UTWbMkVaA7ah95HLSK2n3458okO1X7e6dOe5oQ8130_provenance.
• NP984105.RAGyG-ehDQ1HV2JZ4j9-vgY3msWUaatpXzyuYgzyX9JJY130_assertion description "[ALK is rendered oncogenic as a result of its fusion to NPM1 in anaplastic large cell lymphoma, to TPM3 or TPM4 in inflammatory myofibroblastic tumor, to EML4 in non-small cell lung carcinoma, and to VCL in renal medullary carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP984105.RAGyG-ehDQ1HV2JZ4j9-vgY3msWUaatpXzyuYgzyX9JJY130_provenance.
• NP768712.RANvIEBBlNBHf7r-FypwfXzbwIOCEteFYUS9S4rlvE5YY130_assertion description "[ALK is rendered oncogenic as a result of its fusion to NPM1 in anaplastic large cell lymphoma, to TPM3 or TPM4 in inflammatory myofibroblastic tumor, to EML4 in non-small cell lung carcinoma, and to VCL in renal medullary carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP768712.RANvIEBBlNBHf7r-FypwfXzbwIOCEteFYUS9S4rlvE5YY130_provenance.
• NP756506.RA5JQsMupihGGpqErc2haK0oquhAu2o1TOXUYX9Yig4mY130_assertion description "[ALK is rendered oncogenic as a result of its fusion to NPM1 in anaplastic large cell lymphoma, to TPM3 or TPM4 in inflammatory myofibroblastic tumor, to EML4 in non-small cell lung carcinoma, and to VCL in renal medullary carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756506.RA5JQsMupihGGpqErc2haK0oquhAu2o1TOXUYX9Yig4mY130_provenance.